Peptide in Medical Technology
Navigation Links
Peptide in Medical Technology
... first candidate from the Company's Cationic Lytic peptide (CLYP(TM)) platform technology. EP-100 is a targeted membrane-disrupting peptide and is designed to selectively target luteinizing ... poster presentation entitled, "Targeted Oncolytic peptide for Treatment of Ovarian Cancers" at the American ...
... and weight-lowering actions of AC164209, a peptide hybrid linking a glucagon-like peptide-1 (GLP-1) ... 8. Corporate-sponsored symposium: "Emerging peptide Hormone Therapies for the Treatment of ... help healthcare providers understand the peptide hormone approach to the treatment of ....
... to the development of proprietary peptide, peptide mimetic and small molecule compounds with a focus on melanocortin and natriuretic peptide receptor systems. The melanocortin system is ... inflammation-related diseases. The natriuretic peptide receptor system has numerous cardiovascular ...
... the composition of matter for its PI-2301 peptide copolymer for the treatment of autoimmune ... the development of our intellectual property in peptide copolymers, including PI-2301," stated Thomas P. ... diseases." PI-2301 is a second-generation peptide copolymer from a similar compound class as ...
... presented early clinical results from its PI-2301 peptide copolymer program at both the 17th Annual ENS ... SC administration of the second-generation peptide copolymer PI-2301. This study demonstrated ... PI-2301 is a second generation peptide copolymer from a similar compound class as ...
... and pharmacodynamics of PI-2301, a novel peptide copolymer for the treatment of multiple sclerosis ... convenience." PI-2301 is a second generation peptide copolymer from a similar compound class as ... been optimized using Peptimmune's novel platform peptide chemistry and in pre- clinical studies, has shown ...
... and pharmacodynamics of PI-2301, a novel peptide copolymer for the treatment of multiple sclerosis ... in early 2008. PI-2301 is a second generation peptide copolymer from a similar compound class as ... been optimized using Peptimmune's novel platform peptide chemistry and in pre- clinical studies, has shown ...
... (EPO) linked to Modigene's carboxyl terminal peptide (CTP) technology significantly increased the ... short amino acid sequence, the Carboxyl Terminal peptide (CTP). CTP occurs naturally in humans, and ... trials also demonstrated that attaching the CTP peptide did not affect the therapeutic activity of FSH or ...
... analogs play a distinct biological role from the PTH (parathyroid hormone) peptide by activating different signaling responses--PTH regulates calcium ... same extent as PTH, highlighting differing therapeutic effects of the two peptide types on calcium and bone metabolism. About BA058 BA058 is ...
... gamma interferon itself. The L.E.A.P.S. technology combines a small peptide that activates the immune system with a small peptide from a disease-related protein, such as a herpes simplex virus (HSV) ...
... Replikins Ltd. ( www.replikins.com ) last week analyzed the most recent peptide genomic sequence data available and determined that the infectivity of the ... which is now ready for testing. It used the same approach to produce a peptide H5N1 (avian flu) vaccine that successfully blocked low path H5N1. It has ...
... Syncria. Syncria is a novel long-acting form of GLP-1 (glucagon-like peptide 1) created by HGS using its proprietary albumin-fusion technology, and ... Syncria is generated from the genetic fusion of human albumin and GLP-1, a peptide hormone that acts throughout the body to help maintain normal blood-sugar ...
... AEZS-108 represents a new targeting concept in oncology using a cytotoxic peptide conjugate which is a hybrid molecule composed of a synthetic peptide carrier and a well-known cytotoxic agent, doxorubicin. The design of this ...
... the San Diego Convention Center, Room 2. PI-2301 is a second-generation peptide copolymer from a similar compound class as Copaxone(R) (Teva ... held clinical stage biotechnology company focused on the development of peptide therapies to improve the management of chronic autoimmune and inflammatory ...
... either used alone or in combination with other anti-viral drugs. As peptide conjugates, anti-PE agents may be well-suited for use in some of these ... viruses and virus-infected cells. Using a biotin-conjugated form of the peptide drug duramycin, which is known to bind to PE, Dr. Soares and her ...
... demonstrated that this plaque inhibitory activity is still active when peptide fragments of rBChE are used, rather than the full length protein. This may ... corroborate earlier findings, and demonstrate that both rBChE and its peptide fragments could disrupt amyloid beta organization and potentially limit ...
... 65 years of age and an underserved medical condition." Atrial natriuretic peptide (ANP) is a naturally produced peptide hormone involved in regulation of ... of action is believed to relate to diminished affinity for the natriuretic peptide clearance receptor and increased resistance to the enzyme neutral ...
... at the BIO Investor Forum in San Francisco, CA. "The development of a peptide that has natriuretic and renal effects, with relatively little effect on ... Officer of Nile. About CD-NP CD-NP is a rationally-designed synthetic peptide designed to incorporate the optimal components of naturally occurring ...
... at the BIO Investor Forum in San Francisco, CA. "The development of a peptide that has natriuretic and renal effects, with relatively little effect on ... Officer of Nile. About CD-NP CD-NP is a rationally-designed synthetic peptide designed to incorporate the optimal components of naturally occurring ...
... Chimeric peptide Vaccine Aims to Use Memory Imprint to Yield a Strong and ... will present new data regarding the Company's RECALL-VAX(TM) chimeric peptide vaccine technology at the 13th International Congress of Immunology on ...
... patients) over 16 weeks. About Albiglutide Albiglutide is an investigational biological, injectable form of human GLP-1 - a peptide that acts throughout the body to help maintain normal blood sugar levels and to control appetite. Normally, GLP-1 levels rise during a meal to help ...
... of agents have been associated with renal impairment, hypotension and adverse outcomes. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the ...
... groups was diarrhea, and diarrhea was the most common adverse event leading to discontinuation. Linaclotide is a once daily, orally delivered peptide that acts locally in the gut with no detectable systemic exposure at therapeutic doses. Linaclotide is an agonist of guanylate cyclase type-C, a ...
... study will also be presented from 8:30 a.m. to 12:30 p.m. CET on Monday, June 1. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the ...
... attributes, octreotide has been used to treat symptoms associated with metastatic carcinoid tumors (flushing and diarrhea) and vasoactive intestinal peptide (VIP) secreting adenomas (watery diarrhea). In addition, octreotide substantially reduces and in many cases can control growth hormone and/or ...
... that amyloid beta clumps together and eventually kills brain cells. Solanezumab binds specifically to soluble amyloid beta and thereby may draw the peptide away from the brain through the blood. In short-term clinical studies, solanezumab appeared to have dose-dependent effects on amyloid beta in blood ...
... from blood and tissue studies for a large number of diseases from 50 different human tissues representing 60 diseases and contains over one million peptide sequences, mapped to approximately 15,000 genes, combined with over eight million SNPs and haplotypes. OGAP(R) oncology contains proteomic data on ...
FDA Submission of B-R-A-H-M-S MR-proANP Kryptor
... Kryptor Test. Atrial Natriuretic peptide (ANP) is predominantly produced in the atrium of ... and cardiovascular homeostasis. Although this peptide is unstable, the B-R-A-H-M-S-assay detects the ... fragment: the Mid-Regional pro-Atrial Natriuretic peptide (MR-proANP). In contrast to the mature peptide, ...... and weight-lowering actions of AC164209, a peptide hybrid linking a glucagon-like peptide-1 (GLP-1) ... 8. Corporate-sponsored symposium: "Emerging peptide Hormone Therapies for the Treatment of ... help healthcare providers understand the peptide hormone approach to the treatment of ....
... to the development of proprietary peptide, peptide mimetic and small molecule compounds with a focus on melanocortin and natriuretic peptide receptor systems. The melanocortin system is ... inflammation-related diseases. The natriuretic peptide receptor system has numerous cardiovascular ...
... the composition of matter for its PI-2301 peptide copolymer for the treatment of autoimmune ... the development of our intellectual property in peptide copolymers, including PI-2301," stated Thomas P. ... diseases." PI-2301 is a second-generation peptide copolymer from a similar compound class as ...
Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
... bring worldwide rights to FIRAZYR (Icatibant), a peptide based therapeutic for HAE which has received a ... assets include Jerini Ophthalmic, Inc. and JPT peptide Technologies GmbH - Unanimous support from ... Age-related Macular Degeneration (AMD) and JPT peptide Technologies GmbH, ...... presented early clinical results from its PI-2301 peptide copolymer program at both the 17th Annual ENS ... SC administration of the second-generation peptide copolymer PI-2301. This study demonstrated ... PI-2301 is a second generation peptide copolymer from a similar compound class as ...
CureDM's Diabetes Therapy Achieves Major Development Milestone
... the native form. HIP is a 14-amino acid human peptide derived from a specific human gene responsible ... therapy was stopped. About HIP Human proIslet peptide (HIP) stimulates the differentiation ... Hospital campus in Wynnewood, PA, is developing peptide therapeutics using a platform that combines ...... and pharmacodynamics of PI-2301, a novel peptide copolymer for the treatment of multiple sclerosis ... convenience." PI-2301 is a second generation peptide copolymer from a similar compound class as ... been optimized using Peptimmune's novel platform peptide chemistry and in pre- clinical studies, has shown ...
... and pharmacodynamics of PI-2301, a novel peptide copolymer for the treatment of multiple sclerosis ... in early 2008. PI-2301 is a second generation peptide copolymer from a similar compound class as ... been optimized using Peptimmune's novel platform peptide chemistry and in pre- clinical studies, has shown ...
... (EPO) linked to Modigene's carboxyl terminal peptide (CTP) technology significantly increased the ... short amino acid sequence, the Carboxyl Terminal peptide (CTP). CTP occurs naturally in humans, and ... trials also demonstrated that attaching the CTP peptide did not affect the therapeutic activity of FSH or ...
... analogs play a distinct biological role from the PTH (parathyroid hormone) peptide by activating different signaling responses--PTH regulates calcium ... same extent as PTH, highlighting differing therapeutic effects of the two peptide types on calcium and bone metabolism. About BA058 BA058 is ...
... gamma interferon itself. The L.E.A.P.S. technology combines a small peptide that activates the immune system with a small peptide from a disease-related protein, such as a herpes simplex virus (HSV) ...
... Replikins Ltd. ( www.replikins.com ) last week analyzed the most recent peptide genomic sequence data available and determined that the infectivity of the ... which is now ready for testing. It used the same approach to produce a peptide H5N1 (avian flu) vaccine that successfully blocked low path H5N1. It has ...
... Syncria. Syncria is a novel long-acting form of GLP-1 (glucagon-like peptide 1) created by HGS using its proprietary albumin-fusion technology, and ... Syncria is generated from the genetic fusion of human albumin and GLP-1, a peptide hormone that acts throughout the body to help maintain normal blood-sugar ...
... AEZS-108 represents a new targeting concept in oncology using a cytotoxic peptide conjugate which is a hybrid molecule composed of a synthetic peptide carrier and a well-known cytotoxic agent, doxorubicin. The design of this ...
Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
... epitope linked to a T-cell binding ligand (TCBL) can be manufactured by peptide synthesis or by covalently linking the two peptides. Depending upon the ... it would appear that the L.E.A.P.S.(TM) construct represents a chimeric peptide with bi-functional behavior. About CEL-SCI: CEL-SCI Corporation is ...Treatment Corrects Severe Insulin Imbalance in Animal Studies
... or too high, resulting in diabetes. The new study makes use of a peptide (an amino acid compound) called exendin-(9-39) that blocks the action of a ... her study team expects to progress to a larger clinical trial. "If this peptide can be developed into a treatment for children with this common form of ...Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
... available in 2008. About CD-NP CD-NP is a novel chimeric natriuretic peptide in clinical development for an initial indication of acute decompensated ... developing its lead compound, CD-NP, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure; 2NTX-99, a small ...Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
... About CD-NP Nile's lead compound, CD-NP, is a novel chimeric natriuretic peptide in clinical development for an initial indication of acute decompensated ... developing its lead compound, CD-NP, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure; 2NTX-99, a small ...... the San Diego Convention Center, Room 2. PI-2301 is a second-generation peptide copolymer from a similar compound class as Copaxone(R) (Teva ... held clinical stage biotechnology company focused on the development of peptide therapies to improve the management of chronic autoimmune and inflammatory ...
... either used alone or in combination with other anti-viral drugs. As peptide conjugates, anti-PE agents may be well-suited for use in some of these ... viruses and virus-infected cells. Using a biotin-conjugated form of the peptide drug duramycin, which is known to bind to PE, Dr. Soares and her ...
... demonstrated that this plaque inhibitory activity is still active when peptide fragments of rBChE are used, rather than the full length protein. This may ... corroborate earlier findings, and demonstrate that both rBChE and its peptide fragments could disrupt amyloid beta organization and potentially limit ...
Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity
... offer a patient-friendly product to promote weight loss." About PYY peptide YY is a naturally occurring hormone that is believed to function as a ... technologies. Nastech is creating technologies that enable the delivery of peptide and protein therapeutics without the requirement of an injection, which ...Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure
... enrollment in a Phase II clinical trial of Relaxin, a naturally occurring peptide hormone that is being developed for acute heart failure and other acute ... and adverse outcomes. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a targeted vasodilator with demonstrated systemic and ...... 65 years of age and an underserved medical condition." Atrial natriuretic peptide (ANP) is a naturally produced peptide hormone involved in regulation of ... of action is believed to relate to diminished affinity for the natriuretic peptide clearance receptor and increased resistance to the enzyme neutral ...
... at the BIO Investor Forum in San Francisco, CA. "The development of a peptide that has natriuretic and renal effects, with relatively little effect on ... Officer of Nile. About CD-NP CD-NP is a rationally-designed synthetic peptide designed to incorporate the optimal components of naturally occurring ...
... at the BIO Investor Forum in San Francisco, CA. "The development of a peptide that has natriuretic and renal effects, with relatively little effect on ... Officer of Nile. About CD-NP CD-NP is a rationally-designed synthetic peptide designed to incorporate the optimal components of naturally occurring ...
Raptor Pharmaceuticals Provides Update of Product Programs
... BBB. From these experiments, the team selected a lead candidate transport peptide called RAP-2s. In this second year, the team will continue to assess ... which describes their efforts to develop a readily-manufactured RAP-based peptide to act as a delivery vehicle to the liver. Raptor authors include Sara ...... Chimeric peptide Vaccine Aims to Use Memory Imprint to Yield a Strong and ... will present new data regarding the Company's RECALL-VAX(TM) chimeric peptide vaccine technology at the 13th International Congress of Immunology on ...
Neurocrine Biosciences Presents Elagolix Data
... and analgesics (non-steroidal anti-inflammatory drugs) are often ineffective in controlling the symptoms of endometriosis. Likewise, while peptide gonadotropin-releasing hormone (GnRH) agonists such as Lupron(R) (leuprolide acetate) and Zoladex(R) (goserelin acetate) are highly effective in ...... patients) over 16 weeks. About Albiglutide Albiglutide is an investigational biological, injectable form of human GLP-1 - a peptide that acts throughout the body to help maintain normal blood sugar levels and to control appetite. Normally, GLP-1 levels rise during a meal to help ...
Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
... -- Eli Lilly and Company (NYSE: LLY ) announced today new, positive Phase II study results of LY2189265, its investigational glucagon-like peptide 1 (GLP-1) analog administered subcutaneously once-weekly for the treatment of type 2 diabetes. These data will be presented as part of the American ...... of agents have been associated with renal impairment, hypotension and adverse outcomes. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the ...
... groups was diarrhea, and diarrhea was the most common adverse event leading to discontinuation. Linaclotide is a once daily, orally delivered peptide that acts locally in the gut with no detectable systemic exposure at therapeutic doses. Linaclotide is an agonist of guanylate cyclase type-C, a ...
... study will also be presented from 8:30 a.m. to 12:30 p.m. CET on Monday, June 1. About Relaxin Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the ...
... attributes, octreotide has been used to treat symptoms associated with metastatic carcinoid tumors (flushing and diarrhea) and vasoactive intestinal peptide (VIP) secreting adenomas (watery diarrhea). In addition, octreotide substantially reduces and in many cases can control growth hormone and/or ...
... that amyloid beta clumps together and eventually kills brain cells. Solanezumab binds specifically to soluble amyloid beta and thereby may draw the peptide away from the brain through the blood. In short-term clinical studies, solanezumab appeared to have dose-dependent effects on amyloid beta in blood ...
... from blood and tissue studies for a large number of diseases from 50 different human tissues representing 60 diseases and contains over one million peptide sequences, mapped to approximately 15,000 genes, combined with over eight million SNPs and haplotypes. OGAP(R) oncology contains proteomic data on ...
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
... throughout the 4-week treatment period. In both studies the most common adverse event was diarrhea. Linaclotide is a once daily, orally delivered peptide that acts locally in the gut with no detectable systemic exposure at therapeutic doses. Linaclotide is an agonist of guanylate cyclase type-C, a ...Other ContentsopiateopiateopiateopiatedefiantdefiantoppositionaloppositionalgliomagliomagliomagliomaneuritiscancerscancerscancerscancersOther TagsICOICOICOICOICOICOICOICOOther Tagsemployer 2ruled 2knockout 2
(Date:11/24/2009)...crets of the earth,s history locked in its icy dep...e information on the environments that have been s...Now, a team of researchers from nine institutions ...0 million dollars by the National Science Foundati...lly. These scientists will drill through the West ...
(Date:11/24/2009)...search on bacterial communities throughout six lar...poral patterns, suggesting that scientists could u...mate change in the polar regions. The study, publi... Academy of Sciences Early Edition, shows that ba...hronously over time, correlating with seasonal shi...
(Date:11/23/2009)...dence that the "synergistic" effect of early-life ... and indoor endotoxin causes more harm to developi..., Environmental health scientists at the Universi...wn that children exposed to both high levels of tr...g early life are six times more likely to experien...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2FDA to Require Faster Reporting of Food Safety Problems 56440 1FDA to Require Faster Reporting of Food Safety Problems 56440 2Team reveals molecular mechanism underlying a form of diabetes 56437 1Team reveals molecular mechanism underlying a form of diabetes 56437 2Koshland Science Museum explores emerging technology in fall programs 56434 1Koshland Science Museum explores emerging technology in fall programs 56434 2(Date:11/24/2009)...ov.24/PRNewswire/--Mostpeoplelookforwardtokickingo...getherwithfriendsandfamily.TheMacombCountyHealthDe...gtheholidays.Travelingandbeinginlargegroupsareeasy...ayhealthy: ,, VACCINATION ,, Thefirstandmo...togetvaccinatedagainsttheH1N1strainoftheflu.TheMac...
(Date:11/24/2009)...f.,Nov.24/PRNewswire/--Nextmonth,UnitedHealthcarew...pingHispanic-AmericanseniorsunderstandthebasicsofM...takeafreeZumba®Goldclass,aLatin-infusedfitnes...a,rumba,andtango. ,, UnitedHealthcarewilloffert...andengagedwhenlearningabouttheirhealthcareoptions....
(Date:11/24/2009)...Newswire-FirstCall/--CenteneCorporation(NYSE: CNC ...dhasselectedCenteneasoneoftwoCoordinatedCareOrgani...essNetwork(MississippiCAN),acoordinatedcareprogram...ngwiththeDivisiontoexecuteacontractinwhichthecompa...noliaHealthPlan(Magnolia). ,, BasedinJackson,Mi...
(Date:11/24/2009)...the falls that plague older adults, study finds, ... Falls are a leading cause of death among older Am...in contributes to those accidents. , "Pain cont... and is associated with mobility limitations that .... , "Chronic pain, no matter how we measured it...
(Date:11/24/2009)...ewswire-USNewswire/--TheAmericanDentalAssociation(...nnewdentalteammembersaspartofapilotprogramtoimprov...ommunityDentalHealthCoordinator(CDHC)isamemberofth...tshavelimitedaccesstodentalcaretoimprovetheiroralh...ivedentalcareservices--includingscreeningsandfluor...
Breaking Medicine News(10 mins):Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3Health News:ADA Launches Community Dental Health Coordinator Pilot Program at Temple University 2[2] Tips To Enjoy a Flu-Free Holiday Season[1] UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program[0] Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi[1] Chronic Pain Trips Up Seniors[0] ADA Launches Community Dental Health Coordinator Pilot Program at Temple University
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |